Found: 17
Select item for more details and to access through your institution.
Using Exclusion-Based Sample Preparation (ESP) to Reduce Viral Load Assay Cost.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0143631
- By:
- Publication type:
- Article
Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0076158
- By:
- Publication type:
- Article
Determinants of Clinician Knowledge on Aging and HIV/AIDS: A Survey of Practitioners and Policy Makers in Kampala District, Uganda.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0057028
- By:
- Publication type:
- Article
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
- Published in:
- 2016
- By:
- Publication type:
- journal article
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
- Published in:
- BMC Infectious Diseases, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12879-020-05672-6
- By:
- Publication type:
- Article
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225199
- By:
- Publication type:
- Article
Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0211084
- By:
- Publication type:
- Article
Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda.
- Published in:
- Retrovirology, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12977-022-00587-3
- By:
- Publication type:
- Article
Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 11, p. 1749, doi. 10.1093/cid/civ656
- By:
- Publication type:
- Article
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33538-0
- By:
- Publication type:
- Article
Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral Therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
- Published in:
- 2016
- By:
- Publication type:
- journal article